Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: The ENTRANCE study

K. R. Herrlinger*, M. Diculescu, K. Fellermann, H. Hartmann, S. Howaldt, R. Nikolov, A. Petrov, W. Reindl, J. M. Otte, S. Stoynov, U. Strauch, A. Sturm, R. Voiosu, A. Ammendola, B. Dietrich, B. Hentsch, E. F. Stange

*Corresponding author for this work
29 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: The ENTRANCE study'. Together they form a unique fingerprint.

Medicine & Life Sciences